Literature DB >> 2000816

Postheparin lipolytic activity and plasma lipoprotein response to omega-3 polyunsaturated fatty acids in patients with primary hypertriglyceridemia.

S Nozaki1, A Garg, G L Vega, S M Grundy.   

Abstract

The hypotriglyceridemic action of omega-3 (n-3) fatty acids is attributed primarily to reduction in hepatic triglyceride synthesis and reduced secretion of very-low-density lipoproteins (VLDLs). However, increased catabolism of triglyceride-rich lipoproteins was reported and could be due to increased availability of peripheral lipoprotein lipase (LPL) or hepatic lipase (HL). In this study plasma lipoproteins and postheparin activities of LPL and HL were determined in 12 patients with primary hypertriglyceridemia before and during isocaloric substitution of omega-3 fatty acids (10 g/d) for 4 wk. Omega-3 polyunsaturates resulted in 53% and 61% reductions in plasma triglyceride and VLDL-cholesterol concentrations, respectively (P less than 0.0001). However, low-density-lipoprotein (LDL)-cholesterol concentrations increased by 26% (P less than 0.001). Activities of postheparin LPL and HL essentially remained the same. Thus, in patients with primary hypertriglyceridemia, reduction in plasma triglyceride concentrations and increase in LDL-cholesterol concentrations mediated by omega-3 polyunsaturates seem to occur without an increase in LPL or HL activities.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2000816     DOI: 10.1093/ajcn/53.3.638

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  9 in total

1.  Dietary fish oil reduces cholesterol and arachidonic acid levels in chick plasma and very low density lipoprotein.

Authors:  M Castillo; F Amalik; A Linares; E García-Peregrín
Journal:  Mol Cell Biochem       Date:  1999-10       Impact factor: 3.396

2.  Effects of a brisk walk on lipoprotein lipase activity and plasma triglyceride concentrations in the fasted and postprandial states.

Authors:  Jason M R Gill; Sara L Herd; Vandana Vora; Adrianne E Hardman
Journal:  Eur J Appl Physiol       Date:  2003-02-07       Impact factor: 3.078

3.  Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans.

Authors:  G S Rambjør; A I Wålen; S L Windsor; W S Harris
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

4.  Effects of dietary fish oil on the fatty acid composition of the main lipid classes of chick plasma lipoproteins.

Authors:  M Castillo; F Amalik; E García-Fuentes; E García-Peregrín
Journal:  J Physiol Biochem       Date:  2002-09       Impact factor: 4.158

5.  Echium oil reduces plasma lipids and hepatic lipogenic gene expression in apoB100-only LDL receptor knockout mice.

Authors:  Ping Zhang; Elena Boudyguina; Martha D Wilson; Abraham K Gebre; John S Parks
Journal:  J Nutr Biochem       Date:  2007-12-21       Impact factor: 6.048

6.  Effect of dietary fish oil on blood levels of free fatty acids, ketone bodies and triacylglycerol in humans.

Authors:  P C Dagnelie; T Rietveld; G R Swart; T Stijnen; J W van den Berg
Journal:  Lipids       Date:  1994-01       Impact factor: 1.880

7.  Echium oil reduces plasma triglycerides by increasing intravascular lipolysis in apoB100-only low density lipoprotein (LDL) receptor knockout mice.

Authors:  Lolita M Forrest; Christopher M Lough; Soonkyu Chung; Elena Y Boudyguina; Abraham K Gebre; Thomas L Smith; Perry L Colvin; John S Parks
Journal:  Nutrients       Date:  2013-07-12       Impact factor: 5.717

Review 8.  Effect of Nutrient and Micronutrient Intake on Chylomicron Production and Postprandial Lipemia.

Authors:  Charles Desmarchelier; Patrick Borel; Denis Lairon; Marie Maraninchi; René Valéro
Journal:  Nutrients       Date:  2019-06-08       Impact factor: 5.717

9.  Bio F1B hamster: a unique animal model with reduced lipoprotein lipase activity to investigate nutrient mediated regulation of lipoprotein metabolism.

Authors:  Sukhinder Kaur Cheema; Marion L Cornish
Journal:  Nutr Metab (Lond)       Date:  2007-12-10       Impact factor: 4.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.